|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Abbott Laboratories (ABT) Rumored to Buy Production Facilities in Russia, Deal to Make History in Russia's Pharma Market
10/11/2012 8:19:45 AM
A source at the Federal Anti-monopoly Service of Russia has revealed that one of the world’s largest pharmaceutical companies, Abbott Laboratories, has filed an application to acquire the NGO Petrovax Pharm. Abbott could become the first U.S. pharmaceutical company to own production facilities in Russia. According to experts, the size of the forthcoming acquisition is certain to place the deal among the top three in the history of the Russian pharmaceutical market. Petrovax Pharm was founded in 1996 by a team of Russian flu-vaccine researchers, including Rem Petrov, Arkady Nekrasov, Natalya Puchkova, and Rakhim Khaitov. The current CEO, Professor Arkady Nekrasov, was awarded a government prize in 2002 for developing the drugs Grippol (an influenza vaccine) and Polyoxidonium (an immunomodulator). Both drugs are now part of the company’s portfolio.
|
|
|
|
|
|
|
|
|
|
|